English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 4 June 2020, 21:00 HKT/SGT
Share:
    

Source: LABMED
Singapore's LABMED shipped over 20 million masks to meet global demand
Rising Singapore medical equipment company has been supplying much needed masks, PPEs to Covid-19 hotspots worldwide

SINGAPORE, June 4, 2020 - (Media OutReach) - Singapore based LABMED is playing a crucial role in supplying medical masks and medical personal protective equipment (PPE) globally, to countries such as India, Malaysia, Germany and the US.

LABMED's Regional Managing Director, Wilson, and Managing Director, Jason.

To date, LABMED has shipped over 20 million masks globally. With the increase in demand for PPEs and other medical supplies during the current Covid-19 crisis, LABMED's Regional Managing Director, Wilson, elaborates how they are contributing in the fight against this global pandemic, "Our manufacturing plant in China has 480 employees working round the clock to produce medical PPEs. These are all quality products that have received worldwide certifications."

"Our company also recently introduced into Singapore our latest product - the VTM (Virus Transport Medium) kits for the transport and containment of Covid-19 swab test results," adds Jason, who is the Managing Director.

Having collaborated with many well-known organizations to provide R&D and procurement services for specialized medical supplies, LABMED is making its global presence felt in the sales of pharmaceutical devices.

In a short span of four months, from 1 Feb 2020 to 1 June 2020, the company's revenue increased exponentially to hit more than S$35 million.

LABMED had been predominantly supplying their products to the US, Germany and the UAE, however, the developing Covid-19 situation has seen the company enter new markets with the urgent call to supply much needed PPEs from Asia to Covid-19 'hot-spots' in Europe and North America.

About LABMED

LABMED, a subsidiary of Kin Seng Hong Pte Ltd that was established since 1977, is a brand created by Wilson and Jason (known as Labelmed Pte Ltd) that specializes in the manufacture of disposable civil mask, medical mask, surgical mask, KN95-FFP2 mask and other medical instruments. Strategically headquartered in Singapore with access to a wide distribution network both locally and globally. The company has a strong connection in exporting products all over the world, with special focus on the US, France, Germany and United Kingdom.

The company has collaborated with many local well-known medical device companies, MNCs as well as government entities to provide new and existing customers with procurement services for medical supplies such as medical masks, protective suit, rubber gloves, goggles, thermometer, disinfectant, hand lotion, mask production equipment as well as nasal swab test kit for Covid-19.

LABMED has a large inventory of medical masks, they are able to handle fast delivery, and ensure direct-factory price supply. Website: https://thelabmed.com/

For more information, please contact:
Rebecca
Marketing Director
rebecca@labelmed.com.sg

Topic: Press release summary
Source: LABMED

Sectors: Transport & Logistics, Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Masverse Unveils Groundbreaking Blockchain Platform  
Apr 27, 2024 02:40 HKT/SGT
Spritzer Scores Big with 'Meet the Red Legends' Event for Football Fans  
Apr 26, 2024 23:00 HKT/SGT
Announcing Mad About Marketing - A New Member of the Digital Sukoon Private Limited Family  
Apr 26, 2024 22:25 HKT/SGT
FinTech Funding Continues to Surge as Second Edition of Dubai FinTech Summit Commences  
Apr 26, 2024 21:10 HKT/SGT
TIME Interconnect Technology Limited Announces Final Results For The Nine Months Ended 31 December 2023  
Apr 26, 2024 18:26 HKT/SGT
UK advertising reports GBP36.6bn spend in 2023  
Apr 26, 2024 17:30 HKT/SGT
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine  
Apr 26, 2024 15:36 HKT/SGT
Edvantage Group Announces FY2024 Interim Results  
Apr 26, 2024 13:43 HKT/SGT
Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project  
Apr 26, 2024 13:27 HKT/SGT
Imexpharm Corporation Hosts Shareholders, Analysts and Potential Investors at its 2024 Annual General Meeting  
Apr 26, 2024 13:16 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575